Efficacy of Pleurodesis and EGFR TKI in the Treatment of Lung Cancer-mediated Pleural Effusion with EGFR Mutation

K. Li (Chongqing (Chongqing), China), Q. Zhao (Chongqing (Chongqing), China), P. Zhang (Chongqing (Chongqing), China)

Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Session: Novel directions in pleural disease: bench to bedside
Session type: E-poster session
Number: 1148
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Li (Chongqing (Chongqing), China), Q. Zhao (Chongqing (Chongqing), China), P. Zhang (Chongqing (Chongqing), China). Efficacy of Pleurodesis and EGFR TKI in the Treatment of Lung Cancer-mediated Pleural Effusion with EGFR Mutation. 1148

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: